Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3‐year follow‐up
- 3 March 2016
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 32 (6) , 615-622
Abstract
Background Latent autoimmune diabetes in adults (LADA) is a form of autoimmune diabetes with heterogeneous features. This study aimed to investigate the persistent status of glutamic acid decarboxylase antibody (GADA) in patients with LADA and its association with clinical characteristics. Methods This 3-year follow-up study enrolled 107 LADA and 40 type 2 diabetes mellitus (T2DM) patients from Oct 2005 to Dec 2013. GADA titer, epitopes, and clinical characteristics (including fasting C-peptide and HbA1c) in LADA patients were assayed annually. HLA-DQ genotypes were also analyzed. The relationship between the persistence of GADA and clinical characteristics were investigated in LADA patients. Results After 3-year follow-up, 36.5% (39/107) LADA patients remained GADA-positive (persistently positive group); 19.6% (21/107) patients fluctuated positively and negatively (fluctuating group); while 43.9% (47/107) patients became GADA-negative, among which 61.7% (29/47) seroconversions occurred within 6 months follow-up (transiently positive group). The GADA persistently positive group possessed higher titer of GADA than transiently positive group and fluctuant group (all P =0.000),higher reactivities to middle and C-terminal regions of GAD65 than those in transiently positive group (P = 0.001 and P = 0.000, respectively), and lower baseline fasting C-peptide level than T2DM patients and transiently positive group [415(31-1862) vs. 620(220-1658) pmol/L, P = 0.014; 415(31 ~ 1862) vs. 705(64 ~ 1541) pmol/L, P = 0.017, respectively]. The GADA transiently positive group retained a higher HbA1C level when compared to T2DM patients (P = 0.023). In addition, the three LADA groups shared similar frequencies of HLA-DQ susceptible haplotypes that were higher as compared with T2DM. The GADA persistently positive group had a higher annual declining rate in fasting C-peptide than T2DM patients [-14%(-174% ~ 33%) vs. -1%(-27% ~ 28%), P = 0.007]. Conclusion LADA patients with GADA transient positivity account for a large proportion, whose clinical characteristics and HLA-DQ haplotypes are different from that of T2DM. The patients with high titer GADA and reactivities to GADA65 middle and C-terminal regions showed a persistent GADA positivity, in which a worse baseline and accelerated decline of beta cell function need early intervention in the practice.Keywords
Funding Information
- National Key Technology R&D Programme (2012BAI02B04)
- National Clinical Research Centre for Metabolic Disease (2013BAI09B12)
This publication has 22 references indexed in Scilit:
- High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7)European Journal of Endocrinology, 2014
- LADA and CARDS: A Prospective Study of Clinical Outcome in Established Adult-Onset Autoimmune DiabetesDiabetes Care, 2014
- Autoimmune Aspects of Type 2 Diabetes Mellitus - A Mini-ReviewGerontology, 2014
- What are the characteristics of phenotypic type 2 diabetic patients with low-titer GAD65 antibodies?Acta Diabetologica, 2013
- Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study)Diabetes, 2013
- Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapyDiabetes/Metabolism Research and Reviews, 2012
- GADA Titer-Related Risk for Organ-Specific Autoimmunity in LADA Subjects Subdivided according to Gender (NIRAD Study 6)The Journal of Clinical Endocrinology & Metabolism, 2012
- Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunityActa Diabetologica, 2011
- Latent autoimmune diabetes in adults (LADA) should be less latentDiabetologia, 2005
- Optimal Cutoff Point of Glutamate Decarboxylase Antibody Titers in Differentiating Two Subtypes of Adult‐Onset Latent Autoimmune DiabetesAnnals of the New York Academy of Sciences, 2004